Laboratory tests
Author: Otari Nergadze,
Laboratory tests
- Antiphospholipid syndrome (APS)
- Markers of autoimmune connective tissue diseases (CTDs)
- Biochemical markers of bone remodeling and diseases
- Cerebrospinal fluid (CSF) analysis
- Complete blood count (CBC):
- Lipoprotein(a), Lp(a)
- S100 protein tumormarker - a marker associated with brain injury
- Semen analysis (sperm count test)
- Tumor markers tests (cancer biomarkers):
- Alpha-fetoprotein (AFP)
- ALK rearrangement (ctDNA)
- β-2 microglobulin (beta-2)
- BRAF mutation (ctDNA)
- BRCA1/BRCA2 mutation-associated markers (ctDNA)
- CA 19-9, CA 72-4, CA 50, CA 15-3 and CA 125 tumor markers (cancer antigens)
- Calcitonin
- Cancer associated antigen 549 (CA 549)
- Carcinoembryonic antigen (CEA)
- Chromogranin A (CgA)
- Cytokeratin-19 fragment (CYFRA 21-1)
- Estrogen receptor (ER) / Progesterone receptor (PR) (CTCs)
- Gastrin-releasing peptide (GRP)
- HE4 (Human Epididymis Protein 4)
- HER2/neu (serum)
- Human chorionic gonadotrophin (hCG)
- KRAS mutation (ctDNA)
- Lactate dehydrogenase (LDH)
- Mesothelin
- Mucin-like carcinoma-associated antigen (MCA)
- Neuron-specific enolase (NSE)
- Osteopontin
- PD-L1 expression (CTCs or serum)
- ProGRP (Pro-gastrin-releasing peptide)
- Prostate-specific antigen (PSA) test
- S100 protein tumormarker
- Squamous cell carcinoma antigen (SCC)
- Thyroglobulin (Tg)
- Tissue polypeptide antigens (ТРА, TPS)
- Urinalysis:
